Raymond James Financial’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Raymond James Financial's PCVX Position: Q3 2026 in Review
Raymond James Financial increased its Vaxcyte (PCVX) stake by 6.3% in Q3 2026, buying an estimated $1.36M and bringing the position to 392,784 shares worth $22.3M. The position accounts for 0.01% of the portfolio, ranked #1456.
Raymond James Financial first reported a position in PCVX in Q4 2024 and has held it in 8 quarters since. 354 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Raymond James Financial held 392,784 shares of Vaxcyte worth $22.3M as of Q3 2026.
- Raymond James Financial bought 23,378 Vaxcyte shares in Q3 2026, an estimated $1.36M.
- Vaxcyte made up 0.01% of Raymond James Financial's portfolio in Q3 2026, its #1456 holding.
- Raymond James Financial first reported a position in Vaxcyte in Q4 2024 and has held it in 8 quarters since.
- 354 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.